Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds

Toxicology and Applied Pharmacology

Volumn 186, Issue 2, 2003, Pages 110-118

  Hong, Marjorie S ^a,d   Hong, Sandra J ^b,e   Barhoumi, Rola ^b   Burghardt, Robert C ^b   Donnelly, K C ^b   Wild, James R ^c   Venkatraj, Vijayanagaram ^b   Tiffany Castiglioni, Evelyn ^b  

^a Texas AandM University   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d SHELL GLOBAL SOLUTIONS INTERNATIONAL B V   (United States)

^e EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

Author keywords

Ca2+ homeostasis; Mipafox; Neurite extension; Neuroblastoma; Organophosphorus compounds; Paraoxon

Indexed keywords

CALCIUM ION; CARBACHOL; MIPAFOX; NERVE GROWTH FACTOR; ORGANOPHOSPHORUS COMPOUND; PARAOXON;

ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HOMEOSTASIS; HUMAN; HUMAN CELL; HYDROLYSIS; NEUROBLASTOMA CELL; NEUROPATHY; NEUROTOXICITY; TARGET CELL;

ANIMALIA;

EID: 0037437833     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)00016-9     Document Type: Article

References (38)

1. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 21:1981;511-548.
2. Abou-Donia M.B., Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity type I and type II . Annu. Rev. Pharmacol. Toxicol. 30:1990;405-440.
3. Akerman K.E.O., Scott I.G., Andersson I.C. Functional differentiation of human ganglion cell-derived neuroblastoma cell line SH-SY5Y induced by a phorbol ester (TPA). Neurochem. Int. 6:1984;77-80.
4. Barrett D.S., Oehme F.W. A review of organophosphorus ester-induced delayed neurotoxicity. Vet. Hum. Toxicol. 27:1985;22-37.
5. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:1978;3751-3757.
6. Carlson K., Ehrich M. Organophosphorus compounds alter intracellular F-actin content in SH-SY5Y cells. Neurotoxicology. 22:2001;819-827.
7. Dave K.I., Miller C.E., Wild J.R. Characterization of organophosphorus hydrolases and the genetic manipulation of the phoshotriesterase from Pseudomonas diminuta. Chem.-Biol. Interact. 87:1993;55-68.
8. Ecobichon D.J. Toxic effects of pesticides. Amdur M.O., Doull J., Klaassen C.D. Casarett and Doull's Toxicology The Basic Science of Poisons . 1991;565-622 Pergamon Press, New York.
9. Ehrich M., Correll L., Carlson K., Wilcke J., Veronesi B. Examination of culture conditions on esterase activities in human and mouse neuroblastoma cells. In Vitro Toxicol. 8:1995;199-207.
10. Ehrich M., Correll L., Veronesi B. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundam. Appl. Toxicol. 38:1997;55-67.
11. Ehrich M., Correll L., Veronesi B. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Neurotoxicology. 15:1994;309-314.
12. Ehrich M., Intropido L., Costa L.G. Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells. J. Toxicol. Environ. Health. 43:1994;51-63.
13. El-Fawal H.A.H., Jortner B.S., Ehrich M. Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers in vivo and in vitro electrophysiological assessment . Neurotoxicology. 11:1990;573-592.
14. 2+ transients. Nature. 375:1995;784-787.
15. Husain K., Pant S.C., Raza S.K., Singh R., Das Gupta S. A comparative study of delayed neurotoxicity in hens following repeated administration of organophosphorus compounds. Indian J. Physiol. Pharmacol. 39:1995;47-50.
16. Husain K., Vijayaraghavan R., Pant S.C., Raza S.K., Pandey K.S.J. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. Appl. Toxicol. 13:1993;143-145.
17. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters biochemical studies and toxicological applications . Hodgson E., Bend J.R., Philpot R.M. Reviews in Biochemical Toxicology. 1982;141-212 Elsevier, New York.
18. Katz L.S., Marquis J.K. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinossitide hydrolysis in the human Sk-N-SH cell line. Neurotoxicology. 13:1992;365-378.
19. Kocsis J.D., Rand M.N., Lankford K.L., Waxman S.G. Intracellular calcium mobilization and neurite outgrowth in mammalian neurons. J. Neurobiol. 25:1994;252-264.
20. Kuramoto T., Werrbach-Perez K., Perez-Polo J.R., Haber B. Membrane properties of a human neuroblastoma. II. Effects of differentiation. J. Neurosci. Res. 6:1981;441-449.
21. Lai K., Dave K.I., Wild J.R. Bimetallic binding motifs in organophosphorus hydrolase are important for catalysis and structural organization. J. Biol. Chem. 269:1994;16579-16584.
22. 2+ and inositol 1,4,5-triphosphate mass in a human neuroblastoma cell line, SH-SY5Y. Biochem. J. 265:1990;555-562.
23. Li W.F., Casida J.E. Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells. Toxicol. Lett. 98:1998;139-146.
24. Lotti M., Moretto A., Capodicasa E., Bertolazzi M., Peraica M., Scapellato M.L. Contemporary issues in toxicology interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy . Toxicol. Appl. Pharmacol. 121:1993;36-42.
25. National Research Council, Committee on Alternative Chemical Demilitarization Technologies (CACDT), 1993. Alternative Technologies for the Destruction of Chemical Agents and Munitions; Board on Army Science and Technology, Commission on Engineering and Technical Systems. National Academy of Sciences, Washington, DC.
26. Nostrandt A.C., Ehrich M. Development of a model cell culture system in which to study early effects of neuropathy-inducing organophosphorus esters. Toxicol. Lett. 60:1992;107-114.
27. Nostrandt A.C., Ehrich M. Modification of mipafox-induced inhibition of neuropathy target esterase in neuroblastoma cells of human origin. Toxicol. Appl. Pharmacol. 121:1993;36-42.
28. Påhlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanolphorbol-13-acetate. Int. J. Cancer. 28:1981;583-589.
29. Påhlman S., Ruusala A.I., Abrahamsson L., Odelstad L., Nilson K. Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. Cell Differ. 12:1983;165-170.
30. 2+ deregulation on mitochondrial membrane potential and cell viability in nucleated cells following lytic complement attack. Cell Calcium. 15:1994;217-227.
31. Perez-Polo J.R., Werrbach-Perez K., Tiffany-Castiglioni E. A human clonal cell line model of differentiationg neurons. Dev. Biol. 71:1979;341-355.
32. Scott I.G., Akerman K.E.O., Heikkila E., Andersson L.C. Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J. Cell Physiol. 128:1986;285-292.
33. Shea T.B. Neuritogenesis in mouse NB2a/d1 neuroblastoma cells triggering by calcium influx and involvement of actin and tubulin dynamics . Cell Biol. Int. Rep. 14:1990;967-979.
34. 2+ mobilization in a human parotid salivary cell-line HSY. Arch. Oral Biol. 45:2000;621-638.
35. Suwita E., Lapadula D.M., Abou-Donia M.B. Calcium and calmodulin-enhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single oral dose of tri-o-cresyl phosphate. Proc. Natl. Acad. Sci. USA. 3:1986;6174-6178.
36. 2+ ATPase. Proc. Natl. Acad. Sci. USA. 87:1990;2466-2470.
37. van den beukel I., van Kleef R.G.D.M., Oortgiesen M. Direct functional effects of paraoxon on neuronal nicotinic and muscarinic M3 acetylcholine receptors. ATLA. 24:1996;191-199.
38. Veronesi B., Ehrich M. Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol. Appl. Pharmacol. 120:1993;240-246.